Comparative study on methyl- and ethylmercury-induced toxicity in C6 glioma cells and the potential role of LAT-1 in mediating mercurial-thiol complexes uptake

NeuroToxicology

Volumn 38, Issue , 2013, Pages 1-8

  Zimmermann, Luciana T ^a   Santos, Danúbia B ^a   Naime, Aline A ^a   Leal, Rodrigo B ^a   Dórea, José G ^b   Barbosa, Fernando ^c   Aschner, Michael ^d   Rocha, João Batista T ^e   Farina, Marcelo ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Ethylmercury; L Type neutral amino acid carrier transport; Methylmercury; Toxicity

Indexed keywords

AMINO ACID TRANSPORTER; CYSTEINE; ETHYLMERCURY; GLUTATHIONE; LAT 1 PROTEIN; MERCURIAL THIOL COMPLEX; METHIONINE; METHYLMERCURY; ORGANOMERCURY COMPOUND; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; GLIOMA CELL; MEDIAN EFFECTIVE CONCENTRATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

RATTUS;

ETHYLMERCURY; L-TYPE NEUTRAL AMINO ACID CARRIER TRANSPORT; METHYLMERCURY; TOXICITY;

AMINO ACID TRANSPORT SYSTEM L; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; COORDINATION COMPLEXES; CYSTEINE; ETHYLMERCURIC CHLORIDE; GLIOMA; GLUTATHIONE; HIPPOCAMPUS; METHIONINE; METHYLMERCURY COMPOUNDS; RATS;

EID: 84879594818     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.05.015     Document Type: Article

References (48)

1. Amonpatumrat S., Sakurai H., Wiriyasermkul P., Khunweeraphong N., Nagamori S., Tanaka H., et al. l-Glutamate enhances methylmercury toxicity by synergistically increasing oxidative stress. J Pharmacol Sci 2008, 108:280-289.
2. Aschner M., Ceccatelli S. Are neuropathological conditions relevant to ethylmercury exposure?. Neurotox Res 2010, 18:59-68.
3. Aschner M., Clarkson T.W. Methyl mercury uptake across bovine brain capillary endothelial cells in vitro: the role of amino acids. Pharmacol Toxicol 1989, 64:293-297.
4. Aschner M., Eberle N.B., Goderie S., Kimelberg H.K. Methylmercury uptake in rat primary astrocyte cultures: the role of the neutral amino acid transport system. Brain Res 1990, 521:221-228.
5. Aschner M., Syversen T. Methylmercury: recent advances in the understanding of its neurotoxicity. Ther Drug Monit 2005, 27:278-283.
6. 203Hg-methyl mercury uptake in the rat: relationship to the neutral amino acid carrier. Pharmacol Toxicol 1989, 65:17-20.
7. Ballatori N., Clarkson T.W. Developmental changes in the biliary excretion of methylmercury and glutathione. Science 1982, 216:61-63.
8. Ballatori N. Transport of toxic metals by molecular mimicry. Environ Health Perspect 2002, 110(Suppl. 5):689-694.
9. Boado R.J., Li J.Y., Nagaya M., Zhang C., Pardridge W.M. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA 1999, 96:12079-12084.
10. Bridges C.C., Zalups R.K. Transport of inorganic mercury and methylmercury in target tissues and organs. J Toxicol Environ Health B Crit Rev 2010, 13:385-410.
11. Burbacher T.M., Shen D.D., Liberato N., Grant K.S., Cernichiari E., Clarkson T. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 2005, 113:1015-1021.
12. Clarkson T.W., Magos L., Myers G.J. The toxicology of mercury - current exposures and clinical manifestations. N Engl J Med 2003, 349:1731-1737.
13. Clarkson T.W., Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 2006, 36:609-662.
14. Clarkson T.W., Vyas J.B., Ballatori N. Mechanisms of mercury disposition in the body. Am J Ind Med 2007, 50:757-764.
15. del Amo E.M., Urtti A., Yliperttula M. Pharmacokinetic role of l-type amino acid transporters LAT1 and LAT2. Eur J Pharm Sci 2008, 35:161-174.
16. Dórea J.G. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines. Neurochem Res 2011, 36:927-938.
17. Dórea J.G. Making sense of epidemiological studies of young children exposed to thimerosal in vaccines. Clin Chim Acta 2010, 411:1580-1586.
18. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
19. Farina M., Aschner M., Rocha J.B.T. Oxidative stress in MeHg-induced neurotoxicity. Toxicol Appl Pharmacol 2011, 256:405-417.
20. Farina M., Campos F., Vendrell I., Berenguer J., Barzi M., Pons S., et al. Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells. Toxicol Sci 2009, 112:416-426.
21. Farina M., Rocha J.B.T., Aschner M. Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci 2011, 89:555-563.
22. Franco J.L., Posser T., Dunkley P.R., Dickson P.W., Mattos J.J., Martins R., et al. Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase. Free Radic Biol Med 2009, 47:449-457.
23. Franco J.L., Teixeira A., Meotti F.C., Ribas C.M., Stringari J., Garcia Pomblum S.C., et al. Cerebellar thiol status and motor deficit after lactational exposure to methylmercury. Environ Res 2006, 102:22-28.
24. Heggland I., Kaur P., Syversen T. Uptake and efflux of methylmercury in vitro: comparison of transport mechanisms in C6, B35 and RBE4 cells. Toxicol In Vitro 2009, 23:1020-1027.
25. Hintelmann H. Organomercurials. Their formation and pathways in the environment. Met Ions Life Sci 2010, 7:365-401.
26. Hirayama K. Effect of amino acids on brain uptake of methyl mercury. Toxicol Appl Pharmacol 1980, 55:318-323.
27. Hoffmeyer R.E., Singh S.P., Doonan C.J., Ross A.R.S., Hughes R.J., Pickering I.J., et al. Molecular mimicry in mercury toxicology. Chem Res Toxicol 2006, 19:753-759.
28. Kajiwara Y., Yasutake A., Adachi T., Hirayama K. Methylmercury transport across the placenta via neutral amino acid carrier. Arch Toxicol 1996, 70:310-314.
29. Kanai Y., Segawa H., Miyamoto K.i., Uchino H., Takeda E., Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998, 273:23629-23632.
30. Kerper L.E., Ballatori N., Clarkson T.W. Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am J Physiol 1992, 262:R761-R765.
31. Mokrzan E.M., Kerper L.E., Ballatori N., Clarkson T.W. Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L. J Pharmacol Exp Ther 1995, 272:1277-1284.
32. Mutkus L., Aschner J.L., Syversen T., Shanker G., Sonnewald U., Aschner M. In vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells is inhibited by the ethylmercury-containing preservative thimerosal. Biol Trace Elem Res 2005, 105:71-86.
33. Ni M., Li X., Yin Z., Sidoryk-Wȩgrzynowicz M., Jiang H., Farina M., et al. Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity. Glia 2011, 59:810-820.
34. Pless R., Risher J.F. Mercury, infant neurodevelopment, and vaccination. J Pediatr 2000, 136:571-573.
35. Rabenstein D.L., Isab A.A., Reid R.S. A proton nuclear magnetic resonance study of the binding of methylmercury in human erythrocytes. Biochim Biophys Acta Mol Cell Res 1982, 720:53-64.
36. Rodrigues J.L., de Souza S.S., de Oliveira Souza V.C., Barbosa F. Methylmercury and inorganic mercury determination in blood by using liquid chromatography with inductively coupled plasma mass spectrometry and a fast sample preparation procedure. Talanta 2010, 80:1158-1163.
37. Roos D.H., Puntel R.L., Lugokenski T.H., Ineu R.P., Bohrer D., Burger M.E., et al. Complex methylmercury-cysteine alters mercury accumulation in different tissues of mice. Basic Clin Pharmacol Toxicol 2010, 107:789-792.
38. Roos D.H., Puntel R.L., Farina M., Aschner M., Bohrer D., Rocha J.B., et al. Modulation of methylmercury uptake by methionine: prevention of mitochondrial dysfunction in rat liver slices by a mimicry mechanism. Toxicol Appl Pharmacol 2011, 252(1):28-35.
39. Rush T., Liu X., Lobner D. Synergistic toxicity of the environmental neurotoxins methylmercury and β-N-methylamino-l-alanine. Neuroreport 2012, 23:216-219.
40. Rush T., Liu X., Nowakowski A.B., Petering D.H., Lobner D. Glutathione-mediated neuroprotection against methylmercury neurotoxicity in cortical culture is dependent on MRP1. Neurotoxicology 2012, 33:476-481.
41. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 1999, 274:19745-19751.
42. Shanker G., Syversen T., Aschner J.L., Aschner M. Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes. Brain Res Mol Brain Res 2005, 137:11-22.
43. Simmons-Willis T.A., Koh A.S., Clarkson T.W., Ballatori N. Transport of a neurotoxicant by molecular mimicry: the methylmercury-l-cysteine complex is a substrate for human l-type large neutral amino acid transporter (LAT) 1 and LAT2. Biochem J 2002, 367:239-246.
44. Stringari J., Nunes A.K.C., Franco J.L., Bohrer D., Garcia S.C., Dafre A.L., et al. Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicol Appl Pharmacol 2008, 227:147-154.
45. Vendrell I., Carrascal M., Vilaró M-T., Abián J., Rodríguez-Farré E., Suñol C. Cell viability and proteomic analysis in cultured neurons exposed to methylmercury. Hum Exp Toxicol 2007, 26:263-272.
46. Verrey F. System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch 2003, 445:529-533.
47. Yanagida O., Kanai Y., Chairoungdua A., Kim D.K., Segawa H., Nii T., et al. Human l-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 2001, 1514:291-302.
48. Yin Z., Jiang H., Syversen T., Rocha J.B.T., Farina M., Aschner M. The methylmercury-l-cysteine conjugate is a substrate for the l-type large neutral amino acid transporter. J Neurochem 2008, 107:1083-1090.